BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72 | -91.0% | 1,924 | -89.0% | 0.00% | -100.0% |
| Q2 2023 | $797 | -27.5% | 17,539 | -35.5% | 0.00% | -40.0% |
| Q1 2023 | $1,099 | +1021.4% | 27,182 | +1312.8% | 0.01% | – |
| Q4 2022 | $98 | -99.9% | 1,924 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $103,000 | -16.9% | 1,924 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $124,000 | -16.8% | 1,924 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $149,000 | -86.5% | 1,924 | -85.0% | 0.00% | -75.0% |
| Q4 2021 | $1,100,000 | -1.8% | 12,823 | -8.1% | 0.00% | 0.0% |
| Q3 2021 | $1,120,000 | +297.2% | 13,946 | +297.9% | 0.00% | +300.0% |
| Q2 2021 | $282,000 | +49.2% | 3,505 | +56.2% | 0.00% | 0.0% |
| Q1 2021 | $189,000 | -56.9% | 2,244 | -59.1% | 0.00% | -50.0% |
| Q4 2020 | $439,000 | -79.9% | 5,487 | -79.8% | 0.00% | -77.8% |
| Q3 2020 | $2,185,000 | -22.7% | 27,157 | -17.2% | 0.01% | -25.0% |
| Q2 2020 | $2,826,000 | -21.5% | 32,815 | -20.2% | 0.01% | -20.0% |
| Q3 2019 | $3,598,000 | -76.2% | 41,143 | -77.8% | 0.02% | -76.9% |
| Q1 2019 | $15,092,000 | +5.5% | 185,612 | -14.6% | 0.06% | -8.5% |
| Q4 2018 | $14,308,000 | -54.0% | 217,430 | -46.1% | 0.07% | -44.5% |
| Q3 2018 | $31,071,000 | -35.4% | 403,096 | -38.1% | 0.13% | -38.5% |
| Q2 2018 | $48,083,000 | -18.3% | 651,151 | -28.0% | 0.21% | -18.1% |
| Q1 2018 | $58,833,000 | +38.4% | 904,568 | +37.5% | 0.25% | +38.0% |
| Q4 2017 | $42,523,000 | +164.3% | 657,855 | +156.7% | 0.18% | +159.2% |
| Q3 2017 | $16,086,000 | +532.6% | 256,323 | +510.0% | 0.07% | +491.7% |
| Q2 2017 | $2,543,000 | +39.9% | 42,017 | +19.8% | 0.01% | +50.0% |
| Q1 2017 | $1,818,000 | +2038.8% | 35,059 | +1722.2% | 0.01% | – |
| Q4 2016 | $85,000 | +400.0% | 1,924 | +747.6% | 0.00% | – |
| Q1 2014 | $17,000 | -80.2% | 227 | -81.5% | 0.00% | – |
| Q4 2013 | $86,000 | -88.2% | 1,227 | -89.0% | 0.00% | -100.0% |
| Q3 2013 | $731,000 | – | 11,128 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |